entry price : 8.50 after the breakout (hope there will be volume too) target : 11.5 (32% profit )
•MY Technical Analysis!! Please read it even though it's long. I am sort of new to TA. Please let me know if there are parts that are useless or suck😂 (Looking at the 14th and 15th on a 30 min time frame) -held the 25 ema even during the 15th dip, held the 20 ema all but 1 hour, it then popped up to hold all EMA's. -the last 30 minute volume on the 15th was...
Pupm&Dump trading strategy idea. $LXRX is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $4,45; stop-loss — $5,04; take-profit — $3,86; Do not view this idea as a recommendation for trading or...
Pupm&Dump trading strategy idea. $LXRX is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,50; stop-loss — $2,84; take-profit — $2,16; Do not view this idea as a recommendation for trading or...
Looking for a break (false break?) of crucial $1.70 support and in return expecting to see some opportunities arise for this cheap stock
Movements depend on corporate news but when good new is announced it has hge upside potential. Traders might play the technical break out too. However you may just have to sit on it for a while you never know when biotechs are going to pop but the wait is worth it when they do.
Buy LXRX at $2.30 for target up to $4.30...... see chart
I like this Chart I like their numbers I like my lines LXRX is testing a new frontier... Stand by
Trying hard to breakout of the pullback channel. If it breaks out of the channel with volume in addition to a positive PR then the first target would be the gap fill of 4.16-4.25 and the next target would be 4.85. If it breaks down pull back support would be 2.96
LXRX is a penny stock that has performed well over the last few weeks but looking at the chart, shares are trading within the gap zone. Volume this week compared to previous weeks is lower. Is that a concern or just a slow week? "Shares of LXRX stock have been on a tear for around a month. This was ever since terminating its partnership agreement with Sanofi....
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. SHORT...
Would like to see under yesterday's low around 13.50ish to confirm downward action.